Literature DB >> 11023188

False-negative serology in patients with neuroborreliosis and the value of employing of different borrelial strains in serological assays.

Reinhard Kaiser1.   

Abstract

The risk of obtaining false-negative results in serological assays in serum and CSF specimens with only one strain of Borrelia burgdorferi sensu lato as antigen was investigated in 79 patients with neuroborreliosis with specimens obtained at initial presentation. Serum antibodies were assessed by immunoblotting; the criteria of Hauser et al. were used to evaluate the test. The intrathecal synthesis of borrelial-specific IgM and IgG antibodies was examined by enzyme immunoassay (EIA). Strains of B. burgdorferi sensu stricto (BbZ160), B. garinii (Bbii50) and B. afzelii (PKO) served as sources of antigen in both assays. All patients produced either a positive IgM or IgG test in serum with at least one strain of B. burgdorferi sensu lato. Reactivity of IgM or IgG antibodies, or both, with antigens of all three strains was demonstrated in 67 (85%) of 79 sera. The correlation of results of immunoblotting with different strains was significantly better for IgG (85%) than for IgM antibodies (54%). The variability of positive IgM reactions in 18 specimens was mainly due to the fact that the antibodies were directed to the relevant variable outer-surface protein C (p23). Intrathecal synthesis of IgG antibodies was demonstrated in 58 patients (81%) of 72 and of IgM antibodies in 25 of 58 patients. No patient had isolated intrathecal synthesis of IgM antibodies. The majority of CSF samples (56 of 58) were assessed as IgG antibody-positive, independent of the borrelial strain used as antigen in EIA, whereas only 10 of 25 IgM antibody-positive CSF specimens reacted with all three strains. All patients in the study had intrathecal antibody synthesis demonstrable at 6-week follow-up. From this study it is concluded that there is a small, but real, risk of false-negative serological findings at the time of initial clinical presentation in patients with typical symptoms of neuroborreliosis. In these patients a negative serological result with one strain should prompt the repetition of the test with other strains of B. burgdorferi sensu lato.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023188     DOI: 10.1099/0022-1317-49-10-911

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

Review 1.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

2.  [Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone].

Authors:  R Kaiser
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

3.  Borrelia valaisiana in cerebrospinal fluid.

Authors:  Eudoxia Diza; Anna Papa; Eleni Vezyri; Stefanos Tsounis; Ioannis Milonas; Antonis Antoniadis
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

4.  Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting.

Authors:  Tamara van Gorkom; Willem Voet; Gijs H J van Arkel; Michiel Heron; B J A Hoeve-Bakker; Daan W Notermans; Steven F T Thijsen; Kristin Kremer
Journal:  Microbiol Spectr       Date:  2022-06-21

5.  Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization.

Authors:  Philipp Schwenkenbecher; Refik Pul; Ulrich Wurster; Josef Conzen; Kaweh Pars; Hans Hartmann; Kurt-Wolfram Sühs; Ludwig Sedlacek; Martin Stangel; Corinna Trebst; Thomas Skripuletz
Journal:  BMC Infect Dis       Date:  2017-01-21       Impact factor: 3.090

6.  Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1.

Authors:  Richard I Horowitz; Phyllis R Freeman
Journal:  Int J Gen Med       Date:  2019-02-18

7.  Under-Detection of Lyme Disease in Canada.

Authors:  Vett K Lloyd; Ralph G Hawkins
Journal:  Healthcare (Basel)       Date:  2018-10-15

8.  Serum Epitope Repertoire Analysis Enables Early Detection of Lyme Disease with Improved Sensitivity in an Expandable Multiplex Format.

Authors:  Jack Reifert; Kathy Kamath; Joel Bozekowski; Ewa Lis; Elizabeth J Horn; Dane Granger; Elitza S Theel; John Shon; Jaymie R Sawyer; Patrick S Daugherty
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

9.  Diagnostic pitfalls in a young Romanian ranger with an acute psychotic episode.

Authors:  Előd Ernő Nagy; Attila Rácz; Edit Urbán; Gabriella Terhes; Timea Berki; Emőke Horváth; Anca M Georgescu; Iringó E Zaharia-Kézdi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-03       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.